Characteristics of chronic GVHD after cord blood transplantation

Laura Newell, M. E D Flowers, T. A. Gooley, F. Milano, P. A. Carpenter, P. J. Martin, C. Delaney

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Most reports of chronic GVHD after cord blood transplantation (CBT) have utilized traditional diagnostic criteria. We used traditional criteria and National Institutes of Health (NIH) criteria prospectively to evaluate chronic GVHD in a cohort of 87 adult and pediatric recipients of single or double unrelated CBT for treatment of hematologic malignancies. Fifty-four patients developed traditionally defined chronic GVHD, for an estimated 2-year probability of 64%. Among 54 patients, 25 (46%) met the NIH criteria for persistent, recurrent or late acute GVHD at onset. Twenty-four (44%) had overlap chronic GVHD, including one who presented initially with late acute GVHD, and only seven (13%) had classic chronic GVHD, including one who also presented initially with late acute GVHD. Among patients who successfully discontinued all systemic immunosuppression (SI), the median time to discontinuation of corticosteroid treatment was 315 days (range 28-977), and the median time to discontinuation of all SI was 353 days (range 67-977). Chronic GVHD diagnosed by traditional criteria after CBT had a predominance of acute GVHD clinical features.

Original languageEnglish (US)
Pages (from-to)1285-1290
Number of pages6
JournalBone Marrow Transplantation
Volume48
Issue number10
DOIs
StatePublished - Oct 2013

Fingerprint

Fetal Blood
Transplantation
National Institutes of Health (U.S.)
Immunosuppression
Hematologic Neoplasms
Adrenal Cortex Hormones
Pediatrics
Therapeutics

Keywords

  • chronic GVHD
  • cord blood transplantation
  • GVHD

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Newell, L., Flowers, M. E. D., Gooley, T. A., Milano, F., Carpenter, P. A., Martin, P. J., & Delaney, C. (2013). Characteristics of chronic GVHD after cord blood transplantation. Bone Marrow Transplantation, 48(10), 1285-1290. https://doi.org/10.1038/bmt.2013.48

Characteristics of chronic GVHD after cord blood transplantation. / Newell, Laura; Flowers, M. E D; Gooley, T. A.; Milano, F.; Carpenter, P. A.; Martin, P. J.; Delaney, C.

In: Bone Marrow Transplantation, Vol. 48, No. 10, 10.2013, p. 1285-1290.

Research output: Contribution to journalArticle

Newell, L, Flowers, MED, Gooley, TA, Milano, F, Carpenter, PA, Martin, PJ & Delaney, C 2013, 'Characteristics of chronic GVHD after cord blood transplantation', Bone Marrow Transplantation, vol. 48, no. 10, pp. 1285-1290. https://doi.org/10.1038/bmt.2013.48
Newell L, Flowers MED, Gooley TA, Milano F, Carpenter PA, Martin PJ et al. Characteristics of chronic GVHD after cord blood transplantation. Bone Marrow Transplantation. 2013 Oct;48(10):1285-1290. https://doi.org/10.1038/bmt.2013.48
Newell, Laura ; Flowers, M. E D ; Gooley, T. A. ; Milano, F. ; Carpenter, P. A. ; Martin, P. J. ; Delaney, C. / Characteristics of chronic GVHD after cord blood transplantation. In: Bone Marrow Transplantation. 2013 ; Vol. 48, No. 10. pp. 1285-1290.
@article{6f0cdbf14c00462a8b8141a9066cf6d6,
title = "Characteristics of chronic GVHD after cord blood transplantation",
abstract = "Most reports of chronic GVHD after cord blood transplantation (CBT) have utilized traditional diagnostic criteria. We used traditional criteria and National Institutes of Health (NIH) criteria prospectively to evaluate chronic GVHD in a cohort of 87 adult and pediatric recipients of single or double unrelated CBT for treatment of hematologic malignancies. Fifty-four patients developed traditionally defined chronic GVHD, for an estimated 2-year probability of 64{\%}. Among 54 patients, 25 (46{\%}) met the NIH criteria for persistent, recurrent or late acute GVHD at onset. Twenty-four (44{\%}) had overlap chronic GVHD, including one who presented initially with late acute GVHD, and only seven (13{\%}) had classic chronic GVHD, including one who also presented initially with late acute GVHD. Among patients who successfully discontinued all systemic immunosuppression (SI), the median time to discontinuation of corticosteroid treatment was 315 days (range 28-977), and the median time to discontinuation of all SI was 353 days (range 67-977). Chronic GVHD diagnosed by traditional criteria after CBT had a predominance of acute GVHD clinical features.",
keywords = "chronic GVHD, cord blood transplantation, GVHD",
author = "Laura Newell and Flowers, {M. E D} and Gooley, {T. A.} and F. Milano and Carpenter, {P. A.} and Martin, {P. J.} and C. Delaney",
year = "2013",
month = "10",
doi = "10.1038/bmt.2013.48",
language = "English (US)",
volume = "48",
pages = "1285--1290",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Characteristics of chronic GVHD after cord blood transplantation

AU - Newell, Laura

AU - Flowers, M. E D

AU - Gooley, T. A.

AU - Milano, F.

AU - Carpenter, P. A.

AU - Martin, P. J.

AU - Delaney, C.

PY - 2013/10

Y1 - 2013/10

N2 - Most reports of chronic GVHD after cord blood transplantation (CBT) have utilized traditional diagnostic criteria. We used traditional criteria and National Institutes of Health (NIH) criteria prospectively to evaluate chronic GVHD in a cohort of 87 adult and pediatric recipients of single or double unrelated CBT for treatment of hematologic malignancies. Fifty-four patients developed traditionally defined chronic GVHD, for an estimated 2-year probability of 64%. Among 54 patients, 25 (46%) met the NIH criteria for persistent, recurrent or late acute GVHD at onset. Twenty-four (44%) had overlap chronic GVHD, including one who presented initially with late acute GVHD, and only seven (13%) had classic chronic GVHD, including one who also presented initially with late acute GVHD. Among patients who successfully discontinued all systemic immunosuppression (SI), the median time to discontinuation of corticosteroid treatment was 315 days (range 28-977), and the median time to discontinuation of all SI was 353 days (range 67-977). Chronic GVHD diagnosed by traditional criteria after CBT had a predominance of acute GVHD clinical features.

AB - Most reports of chronic GVHD after cord blood transplantation (CBT) have utilized traditional diagnostic criteria. We used traditional criteria and National Institutes of Health (NIH) criteria prospectively to evaluate chronic GVHD in a cohort of 87 adult and pediatric recipients of single or double unrelated CBT for treatment of hematologic malignancies. Fifty-four patients developed traditionally defined chronic GVHD, for an estimated 2-year probability of 64%. Among 54 patients, 25 (46%) met the NIH criteria for persistent, recurrent or late acute GVHD at onset. Twenty-four (44%) had overlap chronic GVHD, including one who presented initially with late acute GVHD, and only seven (13%) had classic chronic GVHD, including one who also presented initially with late acute GVHD. Among patients who successfully discontinued all systemic immunosuppression (SI), the median time to discontinuation of corticosteroid treatment was 315 days (range 28-977), and the median time to discontinuation of all SI was 353 days (range 67-977). Chronic GVHD diagnosed by traditional criteria after CBT had a predominance of acute GVHD clinical features.

KW - chronic GVHD

KW - cord blood transplantation

KW - GVHD

UR - http://www.scopus.com/inward/record.url?scp=84885598707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885598707&partnerID=8YFLogxK

U2 - 10.1038/bmt.2013.48

DO - 10.1038/bmt.2013.48

M3 - Article

VL - 48

SP - 1285

EP - 1290

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 10

ER -